Clinical TrialsSearch results
Number of results: 370
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase I/II Study to Evaluate the Safety and Efficacy of JB-101(Induced T Cell With Suppressing Functions), to Induce Operational Tolerance in Living Donor Liver Transplantation.
- Patients with end-stage liver failure undergoing living-donor liver transplantation.
- Uchida Koichiro
- 2020-12-17
Completed
- Study protocol: Evaluation of efficacy and safety of Lascufloxacin for Nursing and Healthcare Associated Pneumonia: single arm, open-label clinical trial
- Nursing and healthcare-associated pneumonia
- Mukae Hiroshi
- 2020-12-16
Completed
- Clinical study for alveolar ridge preservation using Cytrans Elashield
- Dental caries and/or periodontitis
- Ohba Seigo
- 2020-12-09
Completed
- Comparative study of the safety and efficacy of the bio-degradable membranes for guided bone regeneration
- Alveolar bone atrophy
- Seigo Ohba
- 2020-12-09
Completed
- Effectiveness of Etanercept Biosimilar Initiating for Etanercept -Naive Patients, using Ultrasound, Clinical and Biomarker Assessments in Outcomes of Real World Therapy(ENPORT-NGSK Study):Study protocol for an interventional, multicenter, open-label, single-arm clinical trial
- Rheumatoid arthritis
- Kawakami Atsushi
- 2020-11-18
Completed
- ADMIT-NeP Study
- Neuropathic pain
- Nagayasu Takeshi
- 2020-11-17
Completed
- A Study of JNJ-73763989 + Nucleos(t)ide Analog in Participants Co-infected with Hepatitis B and Hepatitis D Virus
- Hepatitis D, Chronic
- Nakama Takahiro
- 2020-10-30
Completed
- Exploratory examination of Efficacy and safety of functional food included 5-aminolevulinic phosphoric acid/sodium ferrous citrate on COVID-19
- COVID-19
- Izumikawa Koichi
- 2020-10-29
Completed
- A randomized, controlled study of baloxavir marboxil compared with oseltamivir in patients with influenza virus infection aged 75 years and older
- Influenza Virus Infection.
- Mukae Hiroshi
- 2020-10-05
Recruiting
- Phase I study of Amrubicin plus CISplatin and concurrent accelerated hyperfractionated thoracic radioTherapy for limited-disease small cell lung cancer
- Limited-disease small cell lung cancer
- Taniguchi Hirokazu
- 2020-09-30